In this interview, we spoke with Steven Cramer about regenerative stroke therapies, including the challenges involved with bringing these into the clinic.
A team of researchers have utilized radiocarbon dating to determine that there is little regeneration of oligodendrocytes in the brains of people living with multiple sclerosis. However, the oligodendrocytes that survive the autoimmune attack can replenish lost myelin.
A research team has developed a new platform for performing chemotactic experiments in order to study neural regeneration mechanisms.
Researchers have reported successful creation of spinal cord neural stem cells that could provide a scalable source of replacements cells for spinal cord injuries.
After careful evaluation of the ‘Right to Try ‘Act, BrainStorm have announced that it will not make NurOwn® available under this legislation at this time.
An international team has utilized neuronal cells programmed from genetically identical pigs to eliminate the need for immunosuppression measures.
A natural human monoclonal antibody protects from axonal injury in different CNS degenerative disease models
Discover the factors that inhibit axon regrowth following CNS injury and the potential therapeutics being developed to overome them, in this special report from Future Neurology.
Sarah Isabel Sheikh talks to Neurodegenerative Disease Management about her research into the development of neuroregenerative-based therapies for multiple sclerosis.
The world’s first pluripotent stem cell-based trial for Parkinson’s disease: an interview with Russell Kern
Russell Kern reports on the 6-month update on the first-in-human clinical study of neural stem cells in patients with Parkinson’s disease.
New study finds pathways required for healing and regeneration are shared between mammals and lampreys.